Data has shown high levels of IL-22 in PsoDermatitis induced by anti-TNF-alpha, compared with “pure” Pso and AD and a persistence of increased serum levels of IL-22 despite the use of IL-17A inhibitors. This evidence concerns the gene IL22 and Alzheimer disease.